Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1973 Dec;35(12):1260–1264. doi: 10.1136/hrt.35.12.1260

Effect of glucagon on infants and children with atrioventricular heart block.

R A Hurwitz
PMCID: PMC458791  PMID: 4759923

Full text

PDF
1260

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gavrilescu S., Streian C., Pop T., Vicas E. Hemodynamic effect of glucagon in patients with chronic complete heart block. Cor Vasa. 1971;13(2):85–91. [PubMed] [Google Scholar]
  2. Glick G., Parmley W. W., Wechsler A. S., Sonnenblick E. H. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res. 1968 Jun;22(6):789–799. doi: 10.1161/01.res.22.6.789. [DOI] [PubMed] [Google Scholar]
  3. Hurwitz R. A. Effect of glucagon on dogs with acute and chronic heart block. Am Heart J. 1971 May;81(5):644–649. doi: 10.1016/0002-8703(71)90007-x. [DOI] [PubMed] [Google Scholar]
  4. LILLEHEI C. W., SELLERS R. D., BONNABEAU R. C., ELIOT R. S. CHRONIC POSTSURGICAL COMPLETE HEART BLOCK. WITH PARTICULAR REFERENCE TO PROGNOSIS, MANAGEMENT, AND A NEW P-WAVE PACEMAKER. J Thorac Cardiovasc Surg. 1963 Oct;46:436–456. [PubMed] [Google Scholar]
  5. Linhart J. W., Barold S. S., Cohen L. S., Hildner F. J., Samet P. Cardiovascular effects of glucagon in man. Am J Cardiol. 1968 Nov;22(5):706–710. doi: 10.1016/0002-9149(68)90209-9. [DOI] [PubMed] [Google Scholar]
  6. Lucchesi B. R. Cardiac actions of glucagon. Circ Res. 1968 Jun;22(6):777–787. doi: 10.1161/01.res.22.6.777. [DOI] [PubMed] [Google Scholar]
  7. NAKAMURA F. F., NADAS A. S. COMPLETE HEART BLOCK IN INFANTS AND CHILDREN. N Engl J Med. 1964 Jun 11;270:1261–1268. doi: 10.1056/NEJM196406112702401. [DOI] [PubMed] [Google Scholar]
  8. Nishimura A., Fortner R. B., Williams J. F., Jr Effect of glucagon on automaticity, threshold for stimulation, and atrioventricular conduction in patients with impaired impulse formation or conduction. Am Heart J. 1972 Sep;84(3):359–365. doi: 10.1016/0002-8703(72)90368-7. [DOI] [PubMed] [Google Scholar]
  9. Nord H. J., Fontanes A. L., Williams J. F., Jr Treatment of congestive heart failure with glucagon. Ann Intern Med. 1970 May;72(5):649–653. doi: 10.7326/0003-4819-72-5-649. [DOI] [PubMed] [Google Scholar]
  10. Parmley W. W., Glick G., Sonnenblick E. H. Cardiovascular effects of glucagon in man. N Engl J Med. 1968 Jul 4;279(1):12–17. doi: 10.1056/NEJM196807042790103. [DOI] [PubMed] [Google Scholar]
  11. Parmley W. W., Sonnenblick E. H. Glucagon: a new agent in cardiac therapy. Am J Cardiol. 1971 Mar;27(3):298–303. doi: 10.1016/0002-9149(71)90307-9. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES